Dr. Jonathan Trent

LRG Medical Advisory Board Issues Statement on the Value of Telemedicine

The LRG Medical Advisory Board issued a statement in response to a NEJM article on telemedicine with the hope that other organizations & physicians will follow suit, advocating for treatment ease & equity.

By |2023-01-09T07:35:05-05:00January 9th, 2023|Advocacy, News, Patient Support|

Trent and Rosenberg of Sylvester Cancer Co-author Sarcoma Book with Other Experts in the Field

Dr. Jonathan Trent, GIST Specialist at Sylvester Cancer Center and Dr. Andrew Rosenberg, also a GIST Specialist at Sylvester, have co-authored a book dedicated to sarcoma diagnosis and management with other sarcoma experts specifically for the purpose of giving oncologists a credible authority to 'go-to' for sarcoma knowledge.

By |2020-10-15T13:06:52-04:00September 24th, 2020|GIST Education, News, Research|

LRG Webcast Series: Novel Therapies in GIST

SPAEN (Sarcoma Patients EuroNet) Presents Webinar Webinar "Novel therapy options in GIST: What's on the horizon?" was presented by Dr. Jonathan Trent, Professor of Medicine, Associate Director, Clinical Research Director, Sarcoma Medical Research Program Sylvester [...]

By |2020-07-09T17:14:00-04:00July 31st, 2019|GIST Education, SDH-Deficient GIST, Video|
Go to Top